Related references
Note: Only part of the references are listed.An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
Clifford R. Jack et al.
ANNALS OF NEUROLOGY (2012)
Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging
William J. Jagust et al.
JOURNAL OF NEUROSCIENCE (2012)
Region-Specific Hierarchy between Atrophy, Hypometabolism, and β-Amyloid (Aβ) Load in Alzheimer's Disease Dementia
Renaud La Joie et al.
JOURNAL OF NEUROSCIENCE (2012)
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
Eric M. Reiman et al.
LANCET NEUROLOGY (2012)
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
D. S. Knopman et al.
NEUROLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Share Paper
